CytomX Therapeutics Inc. (CTMX)
0.67
-0.01 (-1.06%)
At close: Mar 03, 2025, 12:30 PM
CytomX Therapeutics Income Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
| Revenue | 101.21M | 53.16M | 69.57M | 100.36M | 57.49M | 59.5M | 71.62M | 15.04M | 7.71M | 5.08M | 888K |
| Cost of Revenue | n/a | 5.86M | 5.84M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit | 101.21M | 47.31M | 63.73M | 100.36M | 57.49M | 59.5M | 71.62M | 15.04M | 7.71M | 5.08M | 888K |
| Operating Income | -6.48M | -101.33M | -83.78M | -48.6M | -110.89M | -77.87M | -46.26M | -59.59M | -33.2M | -29.77M | -14.96M |
| Interest Income | 9.84M | 1.68M | 255K | 1.84M | 8.37M | 7.64M | 2.67M | 2.42M | 1.31M | 7K | 6K |
| Pretax Income | 3.32M | -99.32M | -83.61M | -46.8M | -102.67M | -70.3M | -43.61M | -58.92M | -35.36M | -30.3M | -15.13M |
| Net Income | -569K | -97.3M | -80.65M | -32.88M | -102.24M | -84.6M | -43.1M | -58.9M | -35.37M | -30.31M | -15.14M |
| Selling & General & Admin | 30.02M | 42.85M | 39.16M | 36.03M | 36.77M | 33.51M | 25.61M | 19.87M | 12.56M | 6.54M | 4.95M |
| Research & Development | 77.68M | 111.65M | 114.19M | 112.94M | 131.62M | 103.87M | 92.28M | 54.76M | 28.36M | 28.3M | 10.89M |
| Other Expenses | n/a | 340K | -83K | -27K | -135K | -68K | -27K | -69K | -1.74M | -55K | 71K |
| Operating Expenses | 107.7M | 154.5M | 153.35M | 148.97M | 168.38M | 137.38M | 117.88M | 74.63M | 40.91M | 34.84M | 15.84M |
| Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.69M | 1.73M | 487K | 254K |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 107.7M | 154.5M | 153.35M | 148.97M | 168.38M | 137.38M | 117.88M | 74.63M | 40.91M | 34.84M | 15.84M |
| Income Tax | 3.89M | -2.02M | -2.96M | -13.91M | -427K | 14.3M | -513K | -19K | 10K | 10K | 10K |
| Shares Outstanding (Basic) | 73.81M | 65.74M | 64.15M | 46.15M | 45.34M | 41.66M | 37.17M | 36.23M | 8.6M | 34.92M | 34.92M |
| Shares Outstanding (Diluted) | 73.81M | 65.74M | 64.15M | 46.15M | 45.34M | 41.66M | 37.17M | 36.23M | 8.6M | 34.92M | 34.92M |
| EPS (Basic) | -0.01 | -1.48 | -1.26 | -0.71 | -2.26 | -2.03 | -1.16 | -1.63 | -4.12 | -0.87 | -0.43 |
| EPS (Diluted) | -0.01 | -1.48 | -1.26 | -0.71 | -2.26 | -2.03 | -1.16 | -1.63 | -4.12 | -0.87 | -0.43 |
| EBITDA | -4.31M | -98.89M | -113.34M | -77.97M | -138.88M | -75.99M | -41.97M | -57.85M | -32.43M | -29.03M | -14.22M |
| Depreciation & Amortization | 2.17M | 5.86M | 5.84M | 5.46M | 2.6M | 1.88M | 1.65M | 1.73M | 1.21M | 783K | 655K |